| HPN |
HPN, TMPRSS1: Serine protease hepsin |
F5 |
F5: Coagulation factor V precursor |
0.295 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.295 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
0.295 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
0.295 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
0.295 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
0.295 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.295 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
0.295 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
0.295 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
CSPG2 |
IPI00009802 |
0.295 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
0.295 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.295 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
0.295 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HCK |
IPI00029769 |
0.295 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
0.295 |
Evidence |
|
| THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
EPB41L3 |
EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 |
0.295 |
Evidence |
|
| THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
MAPK8IP1 |
MAPK8IP1, IB1, JIP1, PRKM8IP: C-jun-amino-terminal kinase-interacting protein 1 |
0.295 |
Evidence |
|
| ANXA1 |
ANXA1, ANX1, LPC1: Annexin A1 |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
0.295 |
Evidence |
O
|
| ANXA1 |
ANXA1, ANX1, LPC1: Annexin A1 |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.295 |
Evidence |
|
| ANXA1 |
ANXA1, ANX1, LPC1: Annexin A1 |
S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
0.295 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PLEK |
PLEK, P47: Pleckstrin |
0.295 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
0.295 |
Evidence |
|
| VTN |
VTN: Vitronectin precursor |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.295 |
Evidence |
|
| HPX |
HPX: Hemopexin precursor |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.295 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|